Does Five Session CAT Consultancy Lead to Improved Outcomes?

计划入组 24 人 · 首次发布于 2019 年 6 月 25 日

Ireland Natalizumab (TYSABRI) Observational Program

计划入组 191 人 · 首次发布于 2013 年 9 月 17 日

LOW-PV Continuation

计划入组 36 人 · 首次发布于 2024 年 12 月 31 日

PV-1947D

PV-702

PV-705

PV FIT LIMITED

United Kingdom

Viuture Medical Consultancy Limited

Hong Kong, China

ENTERPRISE IRELAND

EU Veterinary Vaccine and Pharmacovigilance Training Courses Target Regulatory Gaps Under Regulation (2019/6)

Ireland Launches Phase 2 of Precision Oncology Ireland Program with Expanded Investment and Clinical Focus

NFKB1 Haplotype Predicts Improved Response to Ropeginterferon Alfa-2b in PV and ET